THROMBOSPONDIN 2; STRUCTURE EXPRESSION AND FUNCTION
血小板反应蛋白 2;
基本信息
- 批准号:3202426
- 负责人:
- 金额:$ 25.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-08-04 至 1997-05-31
- 项目状态:已结题
- 来源:
- 关键词:RNA biosynthesis affinity chromatography arteriosclerosis autoradiography binding proteins biological products biotechnology cell growth regulation chemical binding extracellular matrix fibroblasts gel electrophoresis gene expression gene mutation genetic manipulation genetic mapping genetic promoter element genetic recombination genetic transcription heparin immunoprecipitation laboratory mouse laboratory rabbit messenger RNA molecular cloning monoclonal antibody neoplastic cell culture for noncancer research nucleic acid hybridization nucleic acid probes nucleic acid sequence online computer plasmids plasminogen platelet derived growth factor platelets protein biosynthesis protein sequence protein structure radiotracer regulatory gene reporter genes thrombosis thrombospondins tissue /cell culture vascular smooth muscle
项目摘要
Human platelet thrombospondin (TSP) is a high molecular weight
glycoprotein (Mr 450,000) composed of three identical disulphide
bonded peptide chains. TSP is a constituent of platelet alpha-
granules and an essential component of the secondary phase of
platelet aggregation. TSP is also synthesized by a variety of cells
including smooth muscle cells, endothelial cells and fibroblasts.
In these cells the synthesized TSP is secreted and incorporated
into the extracellular matrix (ECM). However there is some
recent work which suggests that TSP may serve to regulate aortic
smooth muscle cell (SMC) growth. TSP may also serve as a focus
for protease generation in the ECM by its ability to bind both
plasminogen and tissue plasminogen activator (t-PA).
Since TSP is constituent of both the platelet and the vessel wall
and involved in platelet-platelet and platelet vessel interactions
its study should contribute to the better understanding of its role
in both physiologic and pathologic states (thrombosis, atheroma).
In order to gain greater knowledge about the structure and
regulation of TSP synthesis in the vessel wall the following studies
are proposed: 1) Investigation of the role of the heparin binding
domain (HBD) of TSP with respect to aortic smooth muscle cell
growth. These studies will use a bacterial expression system that
synthesizes the HBD. The isolated HBD will be used to study its
role in aortic smooth muscle cell proliferation. 2) Study of the
gene structure of TSP to better understand the organization and
evolution of the gene. Questions addressed will include, a) Do the
exons code for seperate functional domains? b) Did the TSP gene
evolve to its present form by mechanisms such as gene duplication
and exon shuffling? 3) Investigate the mechanism by which
platelet derived growth factor (PDGF) increases TSP synthesis in
aortic SMC's. Does PDGF increase TSP mRNA by increasing the
transcriptional rate or by stabilizing the mRNA for TSP? 4)
Define the PDGF responsive elements within the TSP gene by use
of gene constructions that consist of the putative regulatory
region fused to a reporter gene (bacterial chloramphenicol acetyl
transferase (CAT)). 5) Study the interaction of TSP with
plasminogen using purified proteins and isolated aortic SMC
matrices. 6) Exploit the ability of carcinoma cells which use TSP
as an attachment factor in trying to localize the cell binding
domain on TSP.
人血小板血小板反应蛋白(TSP)是一种高分子量
由三个相同的二硫键组成的糖蛋白(Mr 450,000)
键合的肽链。 TSP 是血小板α-的组成部分
颗粒和第二相的主要成分
血小板聚集。 TSP也由多种细胞合成
包括平滑肌细胞、内皮细胞和成纤维细胞。
在这些细胞中,合成的 TSP 被分泌并掺入
进入细胞外基质(ECM)。 然而有一些
最近的研究表明 TSP 可能有助于调节主动脉
平滑肌细胞(SMC)生长。 TSP 也可作为焦点
通过其结合两者的能力,在 ECM 中生成蛋白酶
纤溶酶原和组织纤溶酶原激活剂(t-PA)。
由于 TSP 是血小板和血管壁的组成部分
并参与血小板-血小板和血小板血管相互作用
其研究应有助于更好地理解其作用
生理和病理状态(血栓形成、动脉粥样硬化)。
为了更深入地了解其结构和
血管壁中 TSP 合成的调节如下研究
建议:1)研究肝素结合的作用
TSP 与主动脉平滑肌细胞相关的结构域 (HBD)
生长。 这些研究将使用细菌表达系统
合成HBD。 分离的 HBD 将用于研究其
主动脉平滑肌细胞增殖的作用。 2)研究
TSP 的基因结构,以更好地了解组织和
基因的进化。 解决的问题包括:a)
不同功能域的外显子代码? b) TSP 基因是否
通过基因复制等机制进化到现在的形式
和外显子改组? 3)研究其机制
血小板衍生生长因子 (PDGF) 增加 TSP 合成
主动脉 SMC。 PDGF 是否通过增加 TSP mRNA
转录率还是通过稳定 TSP 的 mRNA? 4)
通过使用定义 TSP 基因内的 PDGF 响应元件
由假定的调控组成的基因构建
与报告基因融合的区域(细菌乙酰氯霉素
转移酶(CAT))。 5) 研究TSP与
使用纯化蛋白和分离的主动脉 SMC 进行纤溶酶原
矩阵。 6) 利用癌细胞利用TSP的能力
作为尝试定位细胞结合的附着因子
TSP 上的域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VISHVA M DIXIT其他文献
VISHVA M DIXIT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VISHVA M DIXIT', 18)}}的其他基金
SIGNAL TRANSDUCTION BY THE ECK RECEPTOR TYROSINE KINASE
ECK 受体酪氨酸激酶的信号转导
- 批准号:
2430280 - 财政年份:1996
- 资助金额:
$ 25.14万 - 项目类别:
SIGNAL TRANSDUCTION BY THE ECK RECEPTOR TYROSINE KINASE
ECK 受体酪氨酸激酶的信号转导
- 批准号:
2152830 - 财政年份:1996
- 资助金额:
$ 25.14万 - 项目类别:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
ERB-B-2 表达和对 TNF 杀伤的抵抗力
- 批准号:
2443110 - 财政年份:1994
- 资助金额:
$ 25.14万 - 项目类别:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
ERB-B-2 表达和对 TNF 杀伤的抵抗力
- 批准号:
2107491 - 财政年份:1994
- 资助金额:
$ 25.14万 - 项目类别:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
ERB-B-2 表达和对 TNF 杀伤的抵抗力
- 批准号:
2107493 - 财政年份:1994
- 资助金额:
$ 25.14万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 25.14万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 25.14万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 25.14万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 25.14万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 25.14万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 25.14万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 25.14万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 25.14万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 25.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 25.14万 - 项目类别:
Collaborative Research and Development Grants